Filed with ASX · · 2 pages · English
This filing is a notice regarding the upcoming Annual General Meeting of 4Dmedical Ltd. It clarifies the implications of a specific item related to executive remuneration that will be discussed at the meeting. If the item is not approved, the company may need to pay a significant cash amount to an executive from its reserves. The company has not yet made a decision on alternative remuneration arrangements if the item is not passed.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
ASX announcement ASX:4DX Notice of 2026 Annual General Meeting - Clarification Melbourne, Australia, 23 October 2026: 4DMedical Limited (ASX: 4DX, “4DMedical” or the “Company”), advises further to the release of 4DMedical’s notice of meeting for the upcoming Annual General Meeting...
Follow 4DMedical into a list and get an email when it puts out news.
Follow 4DMedical